SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000947871-24-000751
Filing Date
2024-09-12
Accepted
2024-09-12 16:56:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3236
  Complete submission text file 0000947871-24-000751.txt   5089
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Subject) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38807 | Film No.: 241295561
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022-4629
Business Address 89 MEDINAT HAYEHUDIM STREET, 11TH FLOOR HERZLIYA L3 46766 212-739-6400
OrbiMed Israel GP Ltd. (Reporting) CIK: 0001569590 (see all company filings)

IRS No.: 980697983 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 144